Clinical Trials on Melanoma Metastatic
Total 12023 results
-
Inge Marie SvaneCompleted
-
Hoffmann-La RocheCompleted
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
University of California, IrvineTerminatedMetastatic MelanomaUnited States
-
University Hospital, MontpellierSaint-Louis Hospital, Paris, FranceCompleted
-
Cliniques universitaires Saint-Luc- Université...Terminated
-
AHS Cancer Control AlbertaTransplant Genomics, Inc.Unknown
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
University of ZurichCompleted
-
University of PittsburghBristol-Myers SquibbWithdrawn
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
Hadassah Medical OrganizationCompletedMetastatic MelanomaIsrael
-
Ludwig Institute for Cancer ResearchAgonOxWithdrawn
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Sheba Medical CenterUnknownMetastatic MelanomaIsrael
-
Myrexis Inc.Completed
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
Carman GiacomantonioNova Scotia Health AuthorityWithdrawnCutaneous Metastatic Melanoma
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Wilson MillerActive, not recruitingMetastatic Malignant MelanomaCanada
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
National Cancer Institute (NCI)TerminatedMetastatic Cancer | Metastatic Melanoma | Metastatic Renal CancerUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Cancer | Metastatic Melanoma | Metastatic Renal CancerUnited States
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingMetastatic Colorectal Cancer | Hepatocellular Carcinoma | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Melanoma | Metastatic Uveal Melanoma | Metastatic Pancreatic Cancer | Metastatic Colon Cancer | Metastatic Ocular Melanoma | Cancer Metastatic to the LiverUnited States
-
Vastra Gotaland RegionNot yet recruitingMetastatic Cutaneous Melanoma | Uveal Melanoma
-
Qilu Hospital of Shandong UniversityNot yet recruitingLocally Advanced or Metastatic Acral Malignant MelanomaChina
-
California Cancer Assocaties for Research & ExcellenceUnknownMetastatic Melanoma | Malignant Melanoma of Skin Stage IIIUnited States
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Philogen S.p.A.Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Uveal Melanoma | Metastatic Malignant Neoplasm in the LiverUnited States
-
BiocadActive, not recruitingUnresectable or Metastatic MelanomaRussian Federation
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Bristol-Myers SquibbCompletedAdvanced or Metastatic MelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic (Stage IV) MelanomaFrance
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia